Boehringer Ingelheim will use Virtuosi to train employees at three aseptic sites across its network.
Quality Executive Partners (QxP), global management consulting and educational technology firm, announced on Sept. 20, 2022 that Boehringer Ingelheim has officially deployed its Virtuosi VR education platform for employee training. Boehringer Ingelheim is set to deploy the technology at three aseptic sites across its network.
Virtuosi is a cloud-based learning platform that incorporates 56 courses and 26 VR immersive experiences in more than 100 hours of educational content. According to a company press, its modules are self-paced and fully learning management software-integrated for reporting and evaluation. Additionally, learners receive real-time coaching via responsive formative evaluation, coaching, and haptic feedback.
"QxP is proud to partner with Boehringer Ingelheim, a leading research-driven biopharmaceutical company. Virtuosi is helping Boehringer Ingelheim to further advance the skills and knowledge necessary in sterile manufacturing using tech-forward innovation," said Crystal Mersh, CEO, QxP, in the release.
Source: Quality Executive Partners
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Pfizer Obtains Exclusive Rights to 3SBio’s Bispecific Antibody Targeting PD-1 and VEGF
July 25th 2025The licensing agreement between the two companies gives Pfizer the rights to develop, manufacture, and commercialize 3SBio’s bispecific antibody, SSGJ-707, which is in clinical trials for the treatment of a variety of cancers.